Machine learning enabled subgroup analysis with real-world data to inform better clinical trial design

Jie Xu, Hao Zhang, Hansi Zhang, Jiang Bian, Fei Wang
doi: https://doi.org/10.1101/2021.05.11.21257024

Article Information

doi 
https://doi.org/10.1101/2021.05.11.21257024
History 
  • May 12, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Jie Xu1,*,
  2. Hao Zhang1,*,
  3. Hansi Zhang2,
  4. Jiang Bian2,# and
  5. Fei Wang1,#
  1. 1Department of Population Health Sciences. Weill Cornell Medical College. Cornell University
  2. 2Department of Health Outcomes and Biomedical Informatics. College of Medicine. University of Florida
  1. ↵#Corresponding Authors. Jiang Bian., 2197 Mowry Rd, Suite 122., Gainesville. FL. 32610. USA., bianjiang{at}ufl.edu, Fei Wang., 425 East 61 Street., New York. NY 10065. USA., few2001{at}med.cornell.edu

  1. ↵* Equal Contribution.

Back to top
Posted May 12, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Machine learning enabled subgroup analysis with real-world data to inform better clinical trial design
Jie Xu, Hao Zhang, Hansi Zhang, Jiang Bian, Fei Wang
medRxiv 2021.05.11.21257024; doi: https://doi.org/10.1101/2021.05.11.21257024
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area